Default: Diabetes, Obesity and Metabolism

ISSN: 1462-8902

Journal Home

Journal Guideline

Diabetes, Obesity and Metabolism Q1 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes, Obesity and Metabolism is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 121. It has a price of 3857 €. It has an SJR impact factor of 2,497 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Diabetes, Obesity and Metabolism

2,497

SJR Impact factor

121

H Index

347

Total Docs (Last Year)

842

Total Docs (3 years)

12603

Total Refs

4831

Total Cites (3 years)

765

Citable Docs (3 years)

6,09

Cites/Doc (2 years)

36,32

Ref/Doc


Best articles

5-HT2C receptor modulation and the treatment of obesity

View more

A b3-adrenergic agonist increases muscle GLUT1/GLUT4 ratio, and regulates liver glucose utilization in diabetic rats*

View more

A new air displacement plethysmograph for the determination of Japanese body composition

View more

A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association

View more

Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus

View more

Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct

View more

Adipocyte metabolism and the metabolic syndrome

View more

Aleglitazar, a dual peroxisome proliferator-activated receptor-a/ gamma agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

View more

Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation

View more

Antilipolytic drugs for the prevention of primary ventricular fibrillation

View more

beta3-Adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population

View more

Cardiovascular effects of sulphonylureas: role of KATP channels

View more
SHOW MORE ARTICLES

Cardiovascular risk in type 2 diabetes

View more

Clenbuterol stimulates neurotrophic support in streptozotocin-diabetic rats

View more

Clinical management of diabetic nephropathy

View more

Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking

View more

Clustering of cardiovascular risk factors with diabetes in Chinese patients: the effects of sex and hyperinsulinaemia

View more

Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus

View more

Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity

View more

Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based study

View more

Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project

View more

Dissociation between Fas expression and induction of apoptosis in human islets of Langerhans

View more

Do baseline serum leptin levels predict weight regain after dieting in obese women?

View more

Dysglycaemia in the critically ill - significance and management

View more

Comments

No comments ... Be the first to comment!